This ‘ER‐low’ (5% ER) model was defined as a luminal B cancer in our previous literature13 and its growth was partly facilitated by E2 (but not requiring E2), defining GS1 as an oestrogen‐accelerating luminal breast cancer model (Table S1 and Figure S3). Here, ESR1 is linked to cancer.